Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use - First Single-Shot Vaccine in Fight Against Global Pandemic
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson& Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Clinical Trials | COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | Pandemics | Pharmaceuticals | Vaccines